UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
LIMN holding history
Liminatus Pharma, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LIMN overviewAll 13F holders of LIMNFull Q2 2026 holdings
- Shares (Q2 2026)
- 16,730
- Value
- $1.84K
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q2 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 16,730 | $1.84K | <0.1% | −37,848−69.3% | Reduced | Holders |
| Q1 2026 | 54,578 | $9.39K | <0.1% | +35,183+181.4% | Added | Holders |
| Q4 2025 | 19,395 | $11.8K | <0.1% | −21,131−52.1% | Reduced | Holders |
| Q3 2025 | 40,526 | $67.7K | <0.1% | +9,040+28.7% | Added | Holders |
| Q2 2025 | 31,486 | $351.1K | <0.1% | +31,486 | New | Holders |